3. NOTES RECEIVABLE (Details Narrative) - USD ($) |
6 Months Ended | ||
---|---|---|---|
Jun. 30, 2016 |
Jun. 30, 2015 |
Dec. 31, 2015 |
|
Bad debt expense | $ 28,140 | $ 0 | |
MediJane Holdings Note [Member] | |||
Fair value of products to be returned | 0 | $ 77,330 | |
Bad debt expense | $ 9,218 | ||
Medical Marijuana, Inc. [Member] | Settlement note and accrued interest [Member] | |||
Stock received due to note receivable default, shares | 500,000 | ||
Stock to be received, shares | 124,750 | ||
Medical Marijuana, Inc. [Member] | Promissory note and accrued interest [Member] | |||
Stock held in escrow, shares | 2,000,000 |
X | ||||||||||
- Definition Fair value of products to be returned No definition available.
|
X | ||||||||||
- Definition Stock held in escrow, shares No definition available.
|
X | ||||||||||
- Definition Stock received due to note receivable default, shares No definition available.
|
X | ||||||||||
- Definition Stock To Be Received Shares No definition available.
|
X | ||||||||||
- Definition Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|